Hematologic Adverse Reaction (AR) Monitoring

Blood Counts Should Be Regularly Monitored to Better Manage Hematologic Adverse Reactions1

Monitor complete blood counts weekly for the first month, monthly for the next 11 months of treatment, and periodically after 12 months.

Reference: 1. ZEJULA [package insert]. Waltham, MA: TESARO, Inc; 2017. 

Dose modification

DOSE MODIFICATION

Identify patients who may require an early dose modification

Learn More

Safety data

SAFETY DATA

Learn about the safety and tolerability of ZEJULA

See Safety

Starting ZEJULA

STARTING ZEJULA

When to start ZEJULA

See Recommendations

Dosing guide

DOSING GUIDE

Print the ZEJULA dosing guide

View Guide